Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 417.60
+5.40 (1.31%)
At close: Dec 11, 2025
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 97.38 billion as of December 12, 2025. Its market cap has increased by 153.91% in one year.
Market Cap
97.38B
Enterprise Value
92.58B
Revenue
1.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
417.60
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 97.38B, an increase of 621.89%. That is a compound annual growth rate of 126.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 97.38B | 162.38% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 277.87B |
| Hansoh Pharmaceutical Group Company | 262.50B |
| JD Health International | 184.89B |
| Innovent Biologics | 143.36B |
| WuXi Biologics | 138.21B |
| Sino Biopharmaceutical | 120.31B |
| Akeso | 108.14B |
| CSPC Pharmaceutical Group | 88.83B |